The cdc2-related Kinase, PISSLRE, Is Essential for Cell Growth and Acts in G2 Phase of the Cell Cycle

Cancer Research

Volumn 55, Issue 18, 1995, Pages 3992-3995

  Li, Shu ^a   MacLachlan, Timothy K ^a   De Luca, Antonio ^a   Claudio, Pier Paolo ^a   Condorelli, Gianluigi ^a   Giordano, Antonio ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PISSLRE KINASE; PROTEIN KINASE; CYCLINE;

AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CELL CYCLE G2 PHASE; CELL DIVISION; DNA REPLICATION; HUMAN; MOLECULAR GENETICS; PHYSIOLOGY; CANCER; CELL CYCLE; CELL PROLIFERATION; ENZYME ACTIVATION; GROWTH REGULATION; HUMAN CELL; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; CELL DIVISION; DNA REPLICATION; G2 PHASE; HUMAN; MOLECULAR SEQUENCE DATA; PROTEIN KINASES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0028990868     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Beach, D., Durkacz, B., and Nurse, P. Functionally homologous cell cycle control genes in budding and fission yeast. Nature (Lond.), 300: 706–709, 1982.
2. Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J. W., Elledge, S., Nishimoto, T., Morgan, D. O., Franza, B. R., and Roberts, J. M. Formation and activation of a cyclin E-cdk2 complex during the G., phase of the human cell cycle. Science (Washington DC), 257: 1689–1694, 1992.
3. Nurse, P. Ordering S phase and M phase in the cell cycle. Cell, 79: 547–550, 1994.
4. Elledge, S. J., and Spottswood, M. R. A new human p34 protein kinase, CDK2, identified by complementation of a cdc28 mutation in Saccharomyces cerevisiae, is a homolog of Xenopus Egl. EMBO J., 10: 2653–2659, 1991.
5. MacLachlan, T. K., Sang, N., and Giordano, A. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit. Rev. Eukaryotic Gene Expression, in press, 1995.
6. Xiong, Y., Zhang, H., and Beach, D. D type cyclins associate with multiple protein kinases and the DNA replication factor PCNA. Cell, 71: 505–514, 1992.
7. Xiong, Y., Menninger, J., Beach, D., and Ward, D. C. Molecular cloning and chromosomal mapping of CCND genes encoding D-type cyclins. Genomics, 13: 575–584, 1992.
8. Bates, S., Bonetta, L., MacAllan, D., Parry, D., Holder, A., Dickson, C., and Peters, G. CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin Dl. Oncogene, 9: 71–79, 1994.
9. Chellappan, S. P., Hiebert, S., Mudryj, M., Horowitz, J. M., Nevins, J. R. The E2F transcription factor is a cellular target for the RB protein. Cell, 65: 1053–1061,1991.
10. Resnitzky, D., Gossen, M., Bujard, H., and Reed, S. I. Acceleration of the G,iS phase transition by expression of cyclins Dl and E with an inducible system. Mol. Cell. Biol., 14: 1669–1679, 1994.
11. Giordano, A., Lee, J. H., Scheppler, J. A., Herrmann, C., Harlow, E., Deuschle, U., Beach, D., and Franza, B. R., Jr. Cell cycle regulation of histone HI kinase activity associated with the adenoviral protein El A. Science (Washington DC), 253: 1271–1275, 1991.
12. Hunter, T., and Pines, J. Cyclins and cancer. II. Cyclin D and cdk inhibitors come of age. Cell, 79: 573–582, 1994.
13. Sherr, C. J. G., phase progression: cycling on cue. Cell, 79: 551–555, 1994.
14. Paules, R. S., Levedakou, E. N., Wilson, S. J., Innes, C. L., Rodes, N., Tlsty, T. D., Galloway, D. A., Donehower, L. A., Tainsky, M. A., and Kaufman, W. K. Defective G2 checkpoint function from individuals with familial cancer syndromes. Cancer Res., 55: 1763–1773, 1995.
15. Kaufmann, W. K. Cell cycle checkpoints and DNA repair preserve the stability of the human genome. Cancer Metastasis Rev., 14: 31–41, 1995.
16. Meyerson, M., Enders, G. H., Wu, C. L., Su, L. K., Gorka, C., Nelson, C., Harlow, E., and Tsai, L. H. A family of cdc2-related protein kinases. EMBO J., 11: 2909–2917, 1992.
17. Taylor, S. S., Knighton, D. R., Zheng, J., Sowadski, J. M., Gibbs, C. S., and Zoller, M. J. A template for the protein kinase family. Trends Biochem. Sci., 18: 84–89, 1993.
18. Mendenhall, M. D., Richardson, H. E., and Reed, S. I. Dominant negative protein kinase mutations that confer a G., arrest phenotype. Proc. Natl. Acad. Sci. USA 85: 4426–4430, 1988.
19. Ducommon, B., Brambilla, P., and Draetta, G. Mutations at sites involved in Sucl binding inactivate cdc2. Mol. Cell. Biol., 11: 6177–6184, 1991.
20. Ferrari, G., and Greene, L. A. Proliferative inhibition by dominant-negative Ras rescues naive and neuronally differentiated PC 12 cells from apoptotic death. EMBO J., 13: 5922–5928, 1994.
21. van den Heuvel, S., and Harlow, E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science (Washington DC), 262: 2050–2054, 1993.
22. Grana, X., Claudio, P. P., DeLuca, A., Sang, N., and Giordano, A. PISSLRE, a human novel CDC2-related protein kinase. Oncogene, 9: 2097–2103, 1994.
23. Brambilla, R., and Draetta, G. Molecular cloning of PISSLRE, a novel putative member of the cdk family of protein serine/threonine kinases. Oncogene, 9: 3037–3041, 1994.
24. Bullrich, F., MacLachlan, T. K., Sang, N., Druck, T., Veronese, M. L., Allen, S. L., Chiorazzi, N., Koff, A., Heubner, K., Croce, C. M., and Giordano, A. Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE and PITALRE and a cdk inhibitor, p27Kipl, to regions involved in human cancer. Cancer Res., 55: 1199–1205, 1995.
25. Shen, Y. M., Hirschhorn, R., Mercer, W. E., Surmacz, E., Tsutsui, Y., Soprano, K. J., Baserga, R. Gene transfer: DNA microinjection compared with DNA transfection with a very high efficiency. Mol. Cell. Biol. 2: 1145–1154, 1982.
26. Claudio, P. P., Howard, C. M., Baldi, A., DeLuca, A., Fu, Y., Condorelli, G., Sun, Y., Colburn, N., Calabretta, B., and Giordano, A. pRb2/pl30 has growth-suppressive properties similar to yet distinct from those of retinoblastoma family members pRb and pl07. Cancer Res., 54: 5556–5560, 1994.